—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Amneal Pharmaceuticals, Inc. Class A Common Stock（AMRX）— 同業公司組

數據截至2026-10-28 — 評分每個交易日晚間重新計算。分組標準＝首先為共同的Closelook指數成分，其次為產業。Closelook研究日記，不構成投資建議。

Amneal Pharmaceuticals, Inc. Class A Common Stock的Closelook綜合評分為56/100，在同業公司組內排名第3位（共7家）——組內評分最高的是Laboratorios Farmaceuticos ROVI（62/100）。

名稱綜合動能品質估值訊號距52週高點
AMRX Amneal Pharmaceuticals, Inc. Class A Common Stock56915846ok2.4%
ROVI.MC Laboratorios Farmaceuticos ROVI62337750info28.1%
BHC.TO Bausch Health Companies Inc57817082info12.7%
GALDY GALDERMA GROUP AG56645922info4.3%
IRWD Ironwood Pharmaceuticals Inc56377783warn37.5%
FAGR.BR Fagron NV54575658info5.7%
ALM.MC Almirall S.A.53304663info24.5%

評分為Closelook全部涵蓋範圍內的相對讀數——方法論詳見公司評分說明。訊號燈來自每日夜間訊號看板。

FAQ · from the current data · as of 2026-10-28

Quick answers

Amneal Pharmaceuticals, Inc. Class A Common Stock在Closelook涵蓋範圍內的同業公司有哪些？

分組首先根據共同的Closelook指數成分，其次根據產業：Laboratorios Farmaceuticos ROVI (ROVI.MC)、Bausch Health Companies Inc (BHC.TO)、GALDERMA GROUP AG (GALDY)、Ironwood Pharmaceuticals Inc (IRWD)、Fagron NV (FAGR.BR)、Almirall S.A. (ALM.MC)。

AMRX相對同業公司的評分如何？

Amneal Pharmaceuticals, Inc. Class A Common Stock的綜合評分為56/100，組內排名第3位（共7家），截至2026-10-28；組內最高綜合評分為Laboratorios Farmaceuticos ROVI（62/100）。Closelook評分為研究日記讀數，不構成評等或投資建議。

Related in the Closelooknet universe

then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.